iNCOVACC

iNCOVACC is an intranasal vaccine.

  • An intranasal vaccine stimulates a broad immune response – neutralizing IgG, mucosal IgA, and T cell responses.
  • Immune responses at the site of infection (in the nasal mucosa) – essential for blocking both infection and transmission of COVID-19.
  • The nasal route has excellent potential for vaccination due to the organized immune systems of the nasal mucosa.

It has following advantage –

  • Non-invasive, Needle-free.
  • Ease of administration – does not require trained health care workers.
  • Elimination of needle-associated risks (injuries and infections).
  • High compliance.
  • Scalable manufacturing – able to meet global ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy May 2023 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content

Science & Technology